Search results
- (-) Remove Press releases filter Press releases
Oxford BioMedica secures $50 million loan facility with Oberland Capital to support the Group's growth ambitions
Oxford, UK – 1 May 2015: Oxford BioMedica plc (LSE: OXB), (“Oxford BioMedica” or the “Group”) a leading gene and cell therapy Grou
Oxford BioMedica 2014 Annual Report and Accounts & AGM Notification
London, UK - 2 April 2015: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy gro
Oxford BioMedica to Present at 3rd Annual Regen Med Investor Day
London, UK – 20 March 2015: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE:OXB), a leading gene and cell therapy
2014 Preliminary Results Replay
You have selected Encore.
Oxford BioMedica Announces Presentation at 27th Annual ROTH Conference
Oxford, UK – 5 March 2015: Oxford BioMedica plc (LSE: OXB), (“OXB” or “the Company”) a leading gene and cell therapy company, anno
Oxford BioMedica to Participate in Credit Suisse’s Global Healthcare One-on-One Conference
London, UK – 3 March 2015: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE:OXB), a leading gene and cell therapy c
John Dawson, Chief Executive Officer, presented at Biotech Showcase™ 2015 Conference in San Francisco, on Monday, 12 January 2015
Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with a